Apotex Health Corp. (TSX:APTX)

Apotex Health Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024
Period Ending	Jun 29, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024
Debt / Equity Ratio	-6.31	-6.31	9.12	2.56
Debt / EBITDA Ratio	2.89	2.89	2.34	2.40
Debt / FCF Ratio	6.77	6.77	5.75	3.84
Net Debt / Equity Ratio	-6.21	-6.21	8.85	1.98
Net Debt / EBITDA Ratio	2.91	2.91	2.33	1.94
Net Debt / FCF Ratio	6.66	6.66	5.58	2.98
Asset Turnover	0.74	0.74	0.75	-
Inventory Turnover	1.63	1.63	1.69	-
Quick Ratio	0.77	0.77	0.65	1.02
Current Ratio	1.50	1.50	1.39	1.83
Return on Equity (ROE)	-	-	29.65%	-
Return on Assets (ROA)	14.24%	14.24%	14.03%	-
Return on Invested Capital (ROIC)	25.83%	25.83%	19.31%	28.78%
Return on Capital Employed (ROCE)	34.60%	34.60%	31.30%	23.30%
Payout Ratio	296.87%	296.87%	108.08%	-
Buyback Yield / Dilution	-	-1.77%	-6.11%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every year for this company.

Update frequency:

Yearly

Last checked:

Jul 2, 2026

Data Sources Report a data error